Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Blood|August 15, 1991
Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanismJ A McCubrey, L S Steelman, M W Mayo, et al.Journal of Virology|June 11, 1999
Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3M I Gorziglia, C Lapcevich, S Roy, et al.Journal of Applied Microbiology|March 1, 2017
SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome modelS Connelly, J A Bristol, S Hubert, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|December 3, 1999
In vivo evaluation of a novel epitope-tagged human factor VIII-encoding adenoviral vectorS Roy, P S Shirley, S Connelly, et al.Diabetes|July 27, 2001
Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory proteinE D Slosberg, U J Desai, B Fanelli, et al.Human Gene Therapy|February 1, 1995
In vivo gene delivery and expression of physiological levels of functional human factor VIII in miceS Connelly, T A Smith, G Dhir, et al.Nature Genetics|December 1, 1993
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceT A Smith, M G Mehaffey, D B Kayda, et al.Diabetes|September 28, 2001
Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expressionU J Desai, E D Slosberg, B R Boettcher, et al.Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.Blood|May 23, 1998
Sustained phenotypic correction of murine hemophilia A by in vivo gene therapyS Connelly, J L Andrews, A M Gallo, et al.Pageof 5